文献速递甲状腺疾病

格雷夫斯病放射性碘治疗后新诊断甲状腺癌的发生率未增加

Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该回顾性分析纳入13874例未治疗的格雷夫斯病患者,采用人年法评估各治疗方式后新发甲状腺癌的发病率,未观察到放射性碘治疗后甲状腺癌发病率显著差异。在23179例接受放射性碘治疗的患者中,17例发生甲状腺癌,其中16例为甲状腺乳头状癌,15例为微小癌,逻辑回归未发现显著危险因素。

要点

  • 格雷夫斯病放射性碘治疗后新发甲状腺癌的发病率与药物治疗相比无显著差异。
  • 放射性碘治疗后发生的甲状腺癌多为微小乳头状癌。
  • 逻辑回归分析未识别出甲状腺癌发生的显著危险因素。

核心结论

  • 本研究中,格雷夫斯病放射性碘治疗后新发甲状腺癌的发病率未增加。
  • 放射性碘治疗后发生的大多数甲状腺癌为微小乳头状癌,无证据提示预后不良。

研究设计与样本

  • 回顾性分析13874例符合条件的未治疗格雷夫斯病患者,采用人年法评估各治疗方式后新发甲状腺癌的发病率。
  • 在23179例接受放射性碘治疗的格雷夫斯病患者中,分析治疗后发生甲状腺癌的病例,并采用逻辑回归分析甲状腺癌的危险因素。

主要发现

  • 2273例接受放射性碘治疗,287例接受手术治疗,11314例仅接受药物治疗;放射性碘治疗组新发甲状腺癌8例,药物治疗组39例。
  • 共观察107218人年,格雷夫斯病不同治疗方式间甲状腺癌发病率无显著差异。
  • 23179例接受放射性碘治疗的患者中,17例发生甲状腺癌,其中16例为甲状腺乳头状癌,15例为微小癌。
  • 逻辑回归分析未识别出甲状腺癌发生的显著危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: An analysis based on a large number of detailed patient data was performed to accurately assess the impact of radioiodine therapy (RAIT) for Graves' disease (GD) on thyroid cancer. OBJECTIVE: The purpose was to investigate whether the occurrence of newly diagnosed thyroid cancer is increased after RAIT for GD, and whether thyroid cancer following RAIT has poor prognosis. METHODS: A total of 13 874 eligible patients diagnosed with untreated GD were retrospectively analyzed. The incidence rates of newly developed thyroid cancer by each treatment method for GD was evaluated using the person-year method. Among the 23 179 patients who underwent RAIT for GD, including those with recurrent GD or a history of prior treatment for GD, those who developed thyroid cancer after RAIT were analyzed. Logistic regression analysis was performed to investigate the risk factors for thyroid cancer. RESULTS: A total of 2273 cases underwent RAIT, 287 underwent surgical treatment, and 11 314 were treated with medication only, and new-onset thyroid cancer was identified in 8 patients in the RAIT group and 39 in the medication-only group. A total of 107 218 person-years were observed, but no significant difference was observed in the incidence rate of thyroid cancer with treatment for GD. Of the 23 179 cases that underwent RAIT, 17 developed thyroid cancer. Sixteen were diagnosed with papillary thyroid carcinoma (PTC), of which 15 were microcarcinomas. Logistic regression analysis did not identify any significant risk factors for thyroid cancer development. CONCLUSION: In this study, the incidence of new thyroid cancer cases did not increase following RAIT for GD. Most thyroid cancers that developed after RAIT were micro-PTCs, with no evidence suggesting a poor prognosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hiruma S, Watanabe N, Noh JY, et al. Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease. J Clin Endocrinol Metab. 2025. PMID: 40215268. doi:10.1210/clinem/dgaf231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。